Key facts
- This page summarizes Joseph B. Armes's Form 4 filing for CSW INDUSTRIALS, INC. (CSW).
- 1 reported transaction and 5 derivative rows are listed below.
- Accepted by SEC: 16 Jun 2026, 16:20.
Joseph B. Armes - 15 Jun 2026 Form 4 Insider Report for CSW INDUSTRIALS, INC. (CSW)
- Reporting relationship
- Chairman, President & CEO, Director
- Issuer ticker
- CSW
- Reported as of
- 15 Jun 2026
- Net transaction value
- -$419,277
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2026, 16:20:22 UTC
- Prior SEC filing
- 27 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph B. Armes filed Form 4 for CSW INDUSTRIALS, INC. (CSW) on 16 Jun 2026.
Change
- Previous filing in this sequence was filed on 27 May 2026.
- Current net transaction value: -$419,277.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001413614
Primary reporting owner
Armes Joseph B
- Relationship
- Chairman, President & CEO, Director
- Address
- 5420 LYNDON B JOHNSON FWY, STE. 500, DALLAS
- Signature
- /s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes
- Signature date
- 16 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CSW
transaction
Common Stock
Sale
- Transaction value
- $419,277
- Shares
- -1,500
- Change %
- -2.1%
- Price
- $279.52
- Shares after
- 69,100
- Date
- 15 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F2
CSW
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,219
- Date
- 15 Jun 2026
- Ownership
- by ESOP
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CSW
holding
Derivative
Performance Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,836
- Date
- 15 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,836
- Exercise price
- Footnotes
- F3
CSW
holding
Derivative
Performance Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,004
- Date
- 15 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,004
- Exercise price
- Footnotes
- F4
CSW
holding
Derivative
Performance Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,236
- Date
- 15 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,236
- Exercise price
- Footnotes
- F5
CSW
holding
Derivative
Performance Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,186
- Date
- 15 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,186
- Exercise price
- Footnotes
- F6
CSW
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 19,685
- Date
- 15 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,685
- Exercise price
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 7 footnotes
Footnote F1
The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
Footnote F2
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $278.14 to $280.115, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F3
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 250% during a three-year performance cycle beginning on April 1, 2026 and ending on March 31, 2029 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Footnote F4
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Footnote F5
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Footnote F6
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200%, during a performance cycle beginning April 1, 2021 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Footnote F7
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.